Sign In
Buy SGRY
$14.53
-0.0200 (-0.137%)
At Close: Jun 23, 2026
Surgery Partners, Inc. Names Lloyd Dean to Board of Directors
06:12pm, Thursday, 12'th Mar 2026
BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) recently announced that Lloyd Dean has been appointed to serve a
SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES
09:00am, Wednesday, 11'th Mar 2026
Surgery Partners reported AN Adjusted EBITDA decline of 4.2% in Q4 following projections for continued expanding margins -- Levi & Korsinsky, LLP investigates potential securities law violations NEW Y
Surgery Partners, Inc. (SGRY) Presents at Barclays 28th Annual Global Healthcare Conference Prepared Remarks Transcript
05:10pm, Tuesday, 10'th Mar 2026
Surgery Partners, Inc. (SGRY) Presents at Barclays 28th Annual Global Healthcare Conference Prepared Remarks Transcript
Ortelius Delivers Open Letter to Surgery Partners Stockholders
11:00am, Tuesday, 10'th Mar 2026
NEW YORK--(BUSINESS WIRE)--Ortelius Advisors, L.P. today issued the following open letter to stockholders of Surgery Partners, Inc. (NASDAQ: SGRY). March 10, 2026 Fellow Stockholders, Ortelius Advisor
Fraud Investigation Opened: Levi & Korsinsky Investigates Surgery Partners, Inc. (SGRY) on Behalf of Shareholders
03:15pm, Monday, 09'th Mar 2026
New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Surgery Partners, Inc. ("Surgery Partners, Inc.") (NASDAQ: SGRY)
Surgery Partners, Inc. to Present at Upcoming Investor Conference
12:04pm, Monday, 09'th Mar 2026
BRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), is scheduled to meet with investors at the Barclays 28th Annual Global
Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of “Moderate Buy” from Analysts
02:36am, Monday, 09'th Mar 2026
Surgery Partners, Inc. (NASDAQ: SGRY - Get Free Report) has received an average recommendation of "Moderate Buy" from the twelve analysts that are currently covering the company, Marketbeat.com report
ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS
04:00pm, Wednesday, 04'th Mar 2026
CHICAGO, March 4, 2026 /PRNewswire/ -- Ziegler, a specialty investment bank, is pleased to announce that it served as the exclusive financial advisor to Preferred Vascular Group (PVG) in connection wi
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Surgery Partners, Inc. (NASDAQ: SGRY). The investigation focuses on Surge
Surgery Partners' Plunge Offers An Opportunity For Upside (Rating Upgrade)
02:03am, Wednesday, 04'th Mar 2026
Surgery Partners saw shares drop 14.1% after Q4 2025 results, with revenue beating estimates but profitability disappointing. SGRY expanded surgical facilities and increased revenue per case, but tota
Surgery Partners, Inc. (SGRY) Q4 2025 Earnings Call Transcript
12:22pm, Tuesday, 03'rd Mar 2026
Surgery Partners, Inc. (SGRY) Q4 2025 Earnings Call Transcript
Surgery Partners Stock Hits 52-Week Low - Here's Why
06:53am, Tuesday, 03'rd Mar 2026
Surgery Partners (NASDAQ: SGRY) shares drop in premarket as company reports lower than expected earnings and sets cautious 2026 outlook.
Surgery Partners (SGRY) Lags Q4 Earnings Estimates
06:35pm, Monday, 02'nd Mar 2026
Surgery Partners (SGRY) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.44 per share a year ago.
Surgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Details
01:49pm, Tuesday, 24'th Feb 2026
BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the
Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million
03:03pm, Monday, 23'rd Feb 2026
Irenic Capital sold 1,047,583 shares of Surgery Partners in the fourth quarter; the estimated transaction value was $19.25 million based on average fourth-quarter pricing. The quarter-end position val
